NANoREG – A common European approach to the regulatory testing of Manufactured Nanomaterials

IPH is a partner of this EU FP7 project (Contract Agreement: 310584).

This project is part of a large group of European activities in the field of NANO under the umbrella of NanoSafety Cluster.

The main objectives of this project are:

  • Providing legislators with a set of tools for risk assessment and decision making instruments for the short to medium term, by gathering data and performing pilot risk assessment, including exposure monitoring and control, for a selected number of nanomaterials used in products;
  • Developing for the long term, new testing strategies adapted to a high number of nanomaterials where many factors can affect their environmental and health impact.
  • Establishing a close collaboration among authorities and industry with regard to the knowledge required for appropriate risk management, and create the basis for common approaches, mutually acceptable datasets and risk management practices.

Further information on:


Ing. Karel Lach, CSc.
Telefon +420 604 203 768
Telefon +420 596 200 438

Zdravotní ústav se sídlem v Ostravě
Partyzánské nám. 7, 702 00 Ostrava
Phone: 596 200 111, Fax: 596 118 661, Mail:
Reg-Num: 71009396, Vat-Num: CZ71009396
Bank Connection: Account: 3235761/0710, IBAN: CZ0807100000000003235761, SWIFT: CNBACZPP
Česká národní banka, pobočka Ostrava, Nádražní 4, Ostrava, CZ